About Color Genomics
Color Health is a precision medicine company that has built the first and only ASCO-certified Virtual Cancer Clinic, delivering comprehensive oncologist-led cancer care across the entire cancer journey. The company provides direct clinical care from prevention and early detection through diagnosis, treatment planning, active treatment management, and survivorship care. Color's platform combines board-certified oncologists, AI-powered clinical tools, and at-home testing capabilities to expand access to cancer expertise at scale. The company serves employers, health plans, consultants, unions, and public sector organizations across all 50 states. Color's licensed medical group provides 24/7 access to cancer-specialized physicians who screen, diagnose, prescribe, order tests, manage symptoms, and ensure guideline-based follow-up. The platform integrates with existing healthcare infrastructure and in-network providers while maintaining clinical oversight throughout the patient journey. Color offers at-home screening kits for cervical, prostate, colorectal, and skin cancer, along with physician-directed referrals for breast and lung screening. The company's approach focuses on three key levers: nationwide access to care, speed of diagnosis and treatment, and direct clinical management by oncologists rather than simple navigation. Color Medical provides the clinical care while Color Health provides the platform and support services.
Mission & Story
Mission
We believe people deserve better cancer care
Clinical Focus
Medical conditions and clinical areas addressed by Color Genomics.
Who It Serves
Milestones & Awards
Recent Milestones
First and only Virtual Cancer Clinic to achieve ASCO certification, demonstrating meeting rigorous quality and safety standards as top cancer centers
Awards & Recognition
ASCO Certified - first and only Virtual Cancer Clinic to achieve this certification from the American Society of Clinical Oncology
Key Partnerships
Social & Media
Follow on
Latest Updates
AIUsing AI to help healthcare providers in the cancer spaceRead more
AILLMs in healthcare: tackling implementation challenges methodicallyRead more
Cancer CareColor becomes the first virtual clinic to earn ASCO Certified Designation for quality in cancer careRead more
AIBringing cancer expertise to a doctor near you: Colorâs copilot and partnership with OpenAIRead more
AIUsing AI to accelerate cancer diagnosis to treatment time for your workforceRead more
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Similar Companies in this Market
View all 60 →
23andMe
23andMe uses AI to analyze genetic data and provide personalized health summaries, risk assessments, and wellness recommendations based on genomic insights.
2bPrecise
AI-powered precision medicine platform for personalized treatment recommendations and genomic analysis.
ACT Genomics
AI-powered genomic analysis platform for precision medicine and personalized treatment recommendations.
Adaptive Biotechnologies
Adaptive Biotechnologies uses AI and machine learning to decode the immune system and identify disease-specific immune signatures for diagnosis and personalized treatment.
Ambry Genetics
Ambry Genetics is a leading clinical genetic testing laboratory specializing in hereditary cancer, rare disease, cardiology, and neurology testing. The company provides advanced genetic testing solutions with paired DNA/RNA analysis and comprehensive patient support programs.
Ataraxis
Ataraxis develops AI-native precision medicine tools that predict patient outcomes and treatment response in oncology. Their flagship product, Ataraxis Breast, provides clinically validated prognostic and predictive tests for breast cancer using multi-modal AI analysis of pathology images and clinical data.
Avenda Health
Avenda Health develops Unfold AI, an FDA-cleared artificial intelligence platform that creates 3D cancer estimation maps for prostate cancer. The technology analyzes standard-of-care data (MRI, biopsy, pathology, PSA) to visualize cancer location and extent, helping physicians make more informed treatment decisions and improve patient outcomes.
Base Genomics
Base Genomics appears to be a company in the Precision Medicine & Genomics space, but the scraped website content is empty or inaccessible, preventing detailed analysis of their offerings and target market.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.